Reply to Thread
An internationally operating company based in Germany has a MA for product A in some EU countries. Multinational clinical trials are performed for this product in some EEA countries. How are SUSARs to be reported from spontaneous reports (not originiating from clinical trials)?
Please Please answer this 2 minute Survey for my Thesis
it only take 2 3 minutes of your precious time
i really appreciate your help in this regard
Please also pass it to your Fiends, Colleagues and workers
Thanks in Advance